Citadel Advisors
EVGN icon

Citadel Advisors’s Evogene EVGN Stock Holding History

Citadel Advisors’s Portfolio EVGN Stock Details EVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-88,764
Closed -$97.6K – 13300
2025
Q4 		$97.6K Buy
88,764
+31,189
+54% +$36.4K ﹤0.01% 11662
2025
Q3 		$65.6K Buy
57,575
+36,206
+169% +$45.8K ﹤0.01% 12067
2025
Q2 		$27.4K Buy
+21,369
New +$26.1K ﹤0.01% 12018
2025
Q1 		– Sell
-15,891
Closed -$29.7K – 14753
2024
Q4 		$29.7K Buy
+15,891
New +$31.3K ﹤0.01% 12885
2024
Q3 		– Sell
-2,371
Closed -$15.4K – 14481
2024
Q2 		$15.4K Sell
2,371
-3,620
-60% -$25.3K ﹤0.01% 12832
2024
Q1 		$44.3K Buy
5,991
+319
+6% +$2.66K ﹤0.01% 12290
2023
Q4 		$47.6K Buy
5,672
+2,923
+106% +$18.4K ﹤0.01% 11831
2023
Q3 		$16.1K Buy
2,749
+1,539
+127% +$13.5K ﹤0.01% 12789
2023
Q2 		$12.9K Sell
1,210
-4,483
-79% -$30.3K ﹤0.01% 13060
2023
Q1 		$35.9K Sell
5,693
-2,760
-33% -$20.5K ﹤0.01% 12560
2022
Q4 		$59.2K Sell
8,453
-1,217
-13% -$8.58K ﹤0.01% 11924
2022
Q3 		$80K Buy
+9,670
New +$93.2K ﹤0.01% 11282
2022
Q2 		– Sell
-1,524
Closed -$14.9K – 13169
2022
Q1 		$20K Sell
1,524
-8,546
-85% -$115K ﹤0.01% 13237
2021
Q4 		$165K Buy
10,070
+2,534
+34% +$57.5K ﹤0.01% 12139
2021
Q3 		$199K Sell
7,536
-3,825
-34% -$112K ﹤0.01% 11986
2021
Q2 		$388K Sell
11,361
-3,915
-26% -$153K ﹤0.01% 10644
2021
Q1 		$770K Buy
+15,276
New +$945K ﹤0.01% 8731
2019
Q4 		– Sell
-1,938
Closed -$31K – 9271
2019
Q3 		$31K Buy
+1,938
New +$30.5K ﹤0.01% 8839
2019
Q1 		– Sell
-1,385
Closed -$28K – 9420
2018
Q4 		$28K Buy
+1,385
New +$35K ﹤0.01% 8638

Other funds holding EVGN

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
DSC
Daytona Street Capital Saint Louis, Missouri $130M AUM
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Citadel Advisors's EVGN Position: Q1 2026 in Review

Citadel Advisors sold out of Evogene (EVGN) in Q1 2026, closing a stake of 88,764 shares — an estimated $97.6K sold.

Citadel Advisors first reported a position in EVGN in Q4 2018 and held it in 19 quarters. The position peaked at $770K in Q1 2021. 15 funds tracked by Wall St. Rank hold EVGN as of Q1 2026.

  • Citadel Advisors reported no remaining Evogene position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 88,764 Evogene shares in Q1 2026, an estimated $97.6K.
  • Citadel Advisors first reported a position in Evogene in Q4 2018 and held it in 19 quarters.
  • Citadel Advisors's Evogene position peaked at $770K in Q1 2021.
  • 15 funds tracked by Wall St. Rank held Evogene as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.